Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |